摘要 |
The invention is directed to the succinate salt of trans-4-aminocyclohexyl (1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramenthyl-9-oxotricyclo[5.4.3.01,8]tetradec-6-yl imidodicarbonate (Compound IA). Compound IA is useful for the treatment of a variety of diseases and conditions, such as respiratory tract and skin and skin structure infections. Accordingly, the invention is still further directed to methods of treating respiratory tract and skin and skin structure infections using Compound IA or a pharmaceutical composition comprising Compound IA.
|
申请人 |
GLAXO GROUP LIMITED;DIEDERICH, ANN, MARIE;SISKO, JOSEPH;VOGT, FREDERICK, G. |
发明人 |
DIEDERICH, ANN, MARIE;SISKO, JOSEPH;VOGT, FREDERICK, G. |